Dapsone Gel
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2024-05-09
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 21:03:18
Label at a glance#
Label contents#
Full prescribing information#
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| DAPSONE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4ae3f83f-9ccb-db71-5718-0b1e959868df | Product name | 5 | 20260113 |
| 5ae2790a-f798-4a69-8811-64a4723c389a | Product name | 5 | 20250325 |
| b8929bfc-0002-d39a-046d-72ddf714efbe | Product name | 6 | 20190618 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70771-1538-2 | Dapsone | 1 in 1 CARTON | GEL | 1 | 1 | |
| 70771-1538-2 | Dapsone | 30 g in 1 BOTTLE, PUMP | GEL | 30 | 1 | |
| 70771-1538-3 | Dapsone | 60 g in 1 BOTTLE, PUMP | GEL | 60 | 1 | |
| 70771-1538-3 | Dapsone | 1 in 1 CARTON | GEL | 1 | 1 | |
| 70771-1538-8 | Dapsone | 1 in 1 CARTON | GEL | 1 | 1 | |
| 70771-1538-8 | Dapsone | 90 g in 1 BOTTLE, PUMP | GEL | 90 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70771-1538 | DAPSONE GEL [ZYDUS LIFESCIENCES LIMITED] | 1 | Current NDC, 6 package rows | 20240511_8b63b653-0507-4f95-9bfa-70fd071e15a6.zip |
Products#
Every source-derived product name is available through these pages.
- Dapsone
- ACRYLAMIDE
- DIETHYLENE GLYCOL MONOETHYL ETHER
- ISOHEXADECANE
- METHYLPARABEN
- POLYSORBATE 80
- SODIUM ACRYLOYLDIMETHYLTAURATE
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70771-1538 | 70771-1538-2, 70771-1538-3, 70771-1538-8 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DAPSONE | 8W5C518302 | ACTIB |
| ACRYLAMIDE | 20R035KLCI | IACT |
| DIETHYLENE GLYCOL MONOETHYL ETHER | A1A1I8X02B | IACT |
| ISOHEXADECANE | 918X1OUF1E | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| SODIUM ACRYLOYLDIMETHYLTAURATE | 2T9Q6EKI0G | IACT |
| WATER | 059QF0KO0R | IACT |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A214019-001 | DAPSONE | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A214019-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A214019-001 | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A214019-001 | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A214019-001 | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A214019-001 | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214019-001 | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A214019-001 | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214019-001 | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214019-001 | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214019-001 | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214019-001 | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214019-001 | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214019-001 | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A214019-001 | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A214019-001 | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A214019-001 | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A214019-001 | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A214019-001 | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 | 8072bd15b7f6… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A214019-001 | DAPSONE | 7.5% | GEL / TOPICAL | AB | 2024-05-08 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A214019-001 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A214019-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A214019-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A214019-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214019-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A214019-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214019-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214019-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214019-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214019-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214019-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214019-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A214019-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A214019-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A214019-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A214019-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A214019-001 | AB | 1 | 8072bd15b7f6… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A214019-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dapsone | DAPSONE | Zydus Lifesciences Limited | 8b63b653-0507-4f95-9bfa-70fd071e15a6 | 2024-05-09 | 70771-1538-3 70771-1538-8 70771-1538-2 70771-1538 70771153802 70771153808 70771153803 ae448df2-611f-4d56-911f-11d01983726f 8b63b653-0507-4f95-9bfa-70fd071e15a6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

